Avanir Pharmaceuticals, Inc. (AVNR) Posts Better-Than-Expected Q1 Results

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $7.2 million versus the consensus estimate of $6.49 million.

For earnings history and earnings-related data on Avanir Pharmaceuticals, Inc. (AVNR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Firm Capital Apartment REIT posts Q2 loss, plans name change
• Evolution Petroleum closes $16M Midland Basin royalty acquisition